2 completed, 1 recruiting. 3 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Recruiting 1 |
| Phase 3 | 1 | Completed 1 |
Follow Alcohol Addiction: new trials by email Literature Review of Alcohol Addiction trials Research Report on Alcohol Addiction
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Trial to Investigate the Effects of Cannabidiol Plus Naltrexone on Alcohol Craving in Patients With Alcohol Dependence Cannabidiol capsules, Naltrexone (drug), Placebo - Alcohol Addiction, Alcoholism | Phase 2 | Recruiting | Central Institute of Mental Health, Mannheim | 150 | 2025-07-22 | 2026-02-03 |
| Does Semaglutide Reduce Alcohol Intake in Patients With Alcohol Use Disorder and Comorbid Obesity? Semaglutide Injectable Product, Placebo - Alcohol Abuse, Alcohol Addiction | Phase 2 | Completed | Psychiatric Centre Rigshospitalet | 108 | 2023-06-13 | 2025-08-05 |
| Oxytocin and Naltrexone: Investigation of Combined Effects on Stress- and Alcohol Cue-induced Craving in Alcohol Use Disorder Oxytocin nasal spray, Naltrexone Pill, Placebo - Alcohol Use Disorder, Alcoholism | Phase 2 / Phase 3 | Completed | Central Institute of Mental Health, Mannheim | 62 | 2021-12-02 | 2024-03-29 |
Alcoholism (3)
Alcohol-Related Disorders (3) · Chemically-Induced Disorders (3) · Mental Disorders (3) · Substance-Related Disorders (3)
Naltrexone (2) · Cannabidiol (1) · Pharmaceutical Preparations (1) · Sodium Chloride (1) · semaglutide (1)
Central Institute of Mental Health, Mannheim (2) · Psychiatric Centre Rigshospitalet (1)
Germany (2) · Denmark (1)
Anders Fink-Jensen, MD, DMSc (1) · Patrick Bach, MD (1) · Patrick Bach, Prof. Dr. Dr. (1)
PMID 35410938, PMID 39779270, PMID 40123107, PMID 40803733, PMID 42070571